Shine Medical Technologies has announced that Martyn Coombs will become a strategic adviser on a part-time basis.
The announcement comes as the company prepares to build a facility in Janesville, WI, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The facility will produce molybdenum-99 (Mo-99) and other medical isotopes used to detect and treat a wide variety of diseases, including heart disease and cancer.
Coombs was most recently named CEO of ImaginAb, and he has also served as president of Jubilant DraxImage, where he tripled revenue in four years. He also spent nine years with Amersham/GE Healthcare, including five years in Japan as the executive vice president of Nihon Medi-Physics.
